[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "702 514 4174", "website": "https://www.pasithea.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 75, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 46, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 480000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 345939, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Graeme  Currie Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 346617, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yassine  Bendiabdallah Ph.D.", "age": 39, "title": "COO & Head of UK Clinics", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.85, "open": 6.04, "dayLow": 5.31, "dayHigh": 6.1499, "regularMarketPreviousClose": 5.85, "regularMarketOpen": 6.04, "regularMarketDayLow": 5.31, "regularMarketDayHigh": 6.1499, "beta": 0.742, "forwardPE": -8.577465, "volume": 790532, "regularMarketVolume": 790532, "averageVolume": 938914, "averageVolume10days": 5835270, "averageDailyVolume10Day": 5835270, "bid": 5.68, "ask": 5.72, "bidSize": 100, "askSize": 100, "marketCap": 6358447, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 17.4, "fiftyDayAverage": 4.77148, "twoHundredDayAverage": 6.272095, "currency": "USD", "enterpriseValue": -1609115, "floatShares": 761709, "sharesOutstanding": 1044080, "sharesShort": 419, "sharesShortPriorMonth": 7847, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 1.40768, "heldPercentInstitutions": 0.02873, "shortRatio": 0.03, "shortPercentOfFloat": 0.0005, "bookValue": 15.492, "priceToBook": 0.39310613, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -16370943, "trailingEps": -14.79, "forwardEps": -0.71, "enterpriseToEbitda": 0.099, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "KTTA", "underlyingSymbol": "KTTA", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "firstTradeDateEpochUtc": 1631712600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f19ed9f9-de4f-3b85-b823-68e1246ae624", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.09, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 7967569, "totalCashPerShare": 7.631, "ebitda": -16274925, "quickRatio": 5.712, "currentRatio": 6.196, "returnOnAssets": -0.37903, "returnOnEquity": -0.6325, "freeCashflow": -9018887, "operatingCashflow": -14920285, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-30"}]